Neuren Pharmaceuticals

Neuren is developing compounds that enhance the natural protection and repair mechanisms of the brain and therapeutic compounds that regulate growth and metabolism.

The compounds are under development for the treatment of psychiatric and cognitive effects of neurological injury and diseases, such as those that occur as a result of cardiac surgery, head injury, stroke and Parkinson’s disease.

Neuren's strengths include:

Drugs that are based on naturally occurring molecules and well-characterised biological systems and pathways
Strong intellectual property portfolio covering eight families of compounds
Clinical trial design for robust and cost effective studies
Large target markets with significant unmet need and little or no competition

Corporate Profile